+30.4%
GSK vs EQNR
+85.2%
-54.8%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EQNR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.3% | -0.6% | -2.0% |
| 7D | -1.8% | +1.7% | -3.5% | -1.7% |
| 30D | -2.2% | +11.5% | -13.6% | -1.3% |
| 3M | -1.8% | +12.9% | -14.7% | -1.1% |
| 6M | -10.6% | +36.0% | -46.6% | -9.6% |
| YTD | +4.4% | +84.1% | -79.7% | +4.2% |
| 1Y | +30.4% | +83.8% | -53.3% | +32.1% |
| All | +30.4% | +85.2% | -54.8% | +32.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EQNR.
Daily Out/Under-Performance
Portfolio return minus EQNR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQNR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EQNR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling